| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/20/2011 | CN102026650A Method of preventing premature delivery |
| 04/20/2011 | CN102026649A Method of treating chronic heart failure |
| 04/20/2011 | CN102026648A Pharmaceutical composition for treatment of dry eye and/or corneal/conjunctival disorders |
| 04/20/2011 | CN102026647A Pharmaceutical composition for treating or preventing cancer which induces dendritic cell-like differentiation of monocytes to increase anticancer immune activity |
| 04/20/2011 | CN102026646A Methods and compositions for oral administration of exenatide |
| 04/20/2011 | CN102026619A Liquid buffered GDF-5 formulations |
| 04/20/2011 | CN102021160A Snake venom serine protease and coding gene and application thereof |
| 04/20/2011 | CN102021153A Human telomerase catalytic subunit |
| 04/20/2011 | CN102021136A Discovery and application of gene engineering bacteria and activator for reducing cholesterol |
| 04/20/2011 | CN102020711A Casing smooth muscle collagen preparation method and functional study |
| 04/20/2011 | CN102020710A Novel mutant EN-46 of human epidermal growth factor |
| 04/20/2011 | CN102020709A Mytilus coruscus antibacterial peptide and preparation method and application thereof |
| 04/20/2011 | CN102020704A Methods and compositions for the treatment of gastrointestinal disorders |
| 04/20/2011 | CN102020700A Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/20/2011 | CN102020699A Anti-platelet aggregation peptide and application thereof |
| 04/20/2011 | CN102020698A Hepatitis c virus protease inhibitor |
| 04/20/2011 | CN102020697A Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication |
| 04/20/2011 | CN102018954A Capsule capable of resisting toxicity of radiotherapy and chemotherapy and manufacture process thereof |
| 04/20/2011 | CN102018953A Pharmaceutical composition containing nocathiacin antibiotics |
| 04/20/2011 | CN102018952A Tablet for nourishing liver, protecting liver, sobering up and strengthening kidney and preparation process thereof |
| 04/20/2011 | CN102018726A Method for preparing animal hoof nail extract |
| 04/20/2011 | CN101423555B Membrane penetrating polypeptide for specific inhibition of hepatitis b virus assembly and replication |
| 04/20/2011 | CN101412747B Novel cell-penetrating peptide and uses thereof |
| 04/20/2011 | CN101402688B Fusion protein, encoding gene and uses thereof |
| 04/20/2011 | CN101362798B Candida albicans hyphal development inhibitor and application thereof |
| 04/20/2011 | CN101318995B Substituted tetrahydro-isoquinoline isoquinolinium compound, preparation method and application thereof |
| 04/20/2011 | CN101314769B Staphylokinase and expression vector thereof |
| 04/20/2011 | CN101309678B Medicament for use in connection with cartilage impairment |
| 04/20/2011 | CN101302251B Cyanea-originated glucoprotein having immunopotentiation activity, preparation and use thereof |
| 04/20/2011 | CN101297673B Method for processing fish collagen oligopeptide |
| 04/20/2011 | CN101270157B Genetic engineering target glioma Acp-W1 resistant protein, preparation method and application |
| 04/20/2011 | CN101240027B Conjugate constructed from normal nonyl and RGD peptide, and its synthesis and application in medicine |
| 04/20/2011 | CN101164557B Medical composition for preventing and/or treating bone matrix's loss |
| 04/20/2011 | CN101134105B Pharmaceutical composition containing recombination human pancreatic kininogenase for treating and/or preventing cerebral infarction |
| 04/20/2011 | CN101112358B Staphylokinase intramuscular injection and method for preparing the same |
| 04/20/2011 | CN101100487B Fusion protein capable of removing HPV E7 protein and its encoding gene and application |
| 04/20/2011 | CN101095941B Novel use of leuprorelin acetate in the preventing and treating of osteoporosis |
| 04/20/2011 | CN101068833B Method for producing carboxy-terminal amidified peptides |
| 04/20/2011 | CN101028510B Snake gallbladder for artificial medicine and its production |
| 04/19/2011 | US7928236 Fluorescent amino acid derivatives |
| 04/19/2011 | US7928219 chemically modified nucleic acid molecule; cancer; carcinoma, neovascularization, diabetic retinopathy, neovascular glaucoma, myopic degeneration and other proliferative diseases, restenosis and polycystic kidney disease |
| 04/19/2011 | US7928218 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 04/19/2011 | US7928216 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases |
| 04/19/2011 | US7928213 Nucleic acids encoding chimeric CD154 polypeptides |
| 04/19/2011 | US7928212 Gene upregulated in cancers of the prostate |
| 04/19/2011 | US7928209 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity; DNA |
| 04/19/2011 | US7928201 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 04/19/2011 | US7928199 Stabilized proteins with engineered disulfide bonds |
| 04/19/2011 | US7928196 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer |
| 04/19/2011 | US7928195 Poly zinc finger proteins with improved linkers |
| 04/19/2011 | US7928192 ADP-ribosylating bacterial toxins |
| 04/19/2011 | US7928190 Methods and compositions for tumor vaccination and therapy |
| 04/19/2011 | US7928189 PCSK9 polypeptide fragment |
| 04/19/2011 | US7928187 Neuropeptide alarin |
| 04/19/2011 | US7928186 Cell permeable bioactive peptide conjugates |
| 04/19/2011 | US7928185 Synthetic arginine substituted peptides and their use |
| 04/19/2011 | US7928141 Mixture comprising dexamethasone, vitamin B, metronidazole, berberine, etamsylate, gentamicin, chymotrypsin, methylene blue trihydrate and sodium bicarbonate for improving effectiveness of local anesthetics |
| 04/19/2011 | US7928137 Meta-benzamidine derivatives as serine protease inhibitors |
| 04/19/2011 | US7928086 β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
| 04/19/2011 | US7928082 Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same |
| 04/19/2011 | US7928075 Binding agents which inhibit myostatin |
| 04/19/2011 | US7928074 Using interleukin-1 specfic immunoglobulin fusion and tumor necrosis factor inhibitors to treat inflammatory and/or autoimmune disorders |
| 04/19/2011 | US7928073 Purified polypeptides having IL-13 receptor activity |
| 04/19/2011 | US7928072 Multimeric constructs |
| 04/19/2011 | US7928071 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 04/19/2011 | US7928070 Administering protein kinase C |
| 04/19/2011 | US7928069 Crosslinked compounds and methods of making and using thereof |
| 04/19/2011 | US7928068 Methods for using GEP, a chondrogenic growth factor and target in cartilage disorders |
| 04/19/2011 | US7928067 Compositions and methods for treating ischemia and ischemia-reperfusion injury |
| 04/19/2011 | US7928066 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 04/19/2011 | US7928065 Methods of treatment using exendin peptides or GLP-1 peptides |
| 04/19/2011 | US7928064 Transgenically produced antithrombin III |
| 04/19/2011 | US7928063 Analogs of human growth hormone-releasing hormone, their preparation and use |
| 04/19/2011 | US7928062 inhibiting or disrupting Janus tyrosine kinase 3 (Jak3) dependent function in cells of lymphoid or myeloid origin, especially for blocking proliferation and function of lymphocytes (e.g., T-cells, B-cells). A Mannich base compound, or a derivative or modified |
| 04/19/2011 | US7928061 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications |
| 04/19/2011 | US7928060 Therapy for metabolism disorders, cardiovascular disorders, obesity, antidiabetic agents |
| 04/19/2011 | US7928059 Use of neuropeptides for traumatic cartilage injury |
| 04/19/2011 | US7928058 Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition |
| 04/19/2011 | US7928057 Peptide for inhibition of calcineurin, nucleic acid, antibody, and diagnostic and therapeutic methods of use |
| 04/19/2011 | US7928056 Enzyme treatment of foodstuffs for Celiac Sprue |
| 04/19/2011 | US7928038 Intermediates and methods for forming passivated surfaces on oxide layers and articles produced thereby |
| 04/19/2011 | US7927852 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 04/19/2011 | US7927835 Expression vector comprising nucleotide sequences coding bone morphogenic protein/selectin fusion for use in treatment and prvention of inflammatory diseases |
| 04/19/2011 | US7927824 Complex of a chaperone with β-amyloid and methods employing this complex |
| 04/19/2011 | US7927821 Methods of screening for compounds which bind G protein-coupled receptors |
| 04/19/2011 | US7927816 Methods for identifying modulators of apoptosis |
| 04/19/2011 | US7927811 Binds to cerebrovascular endothelial cell; expression vectors; micelle, liposome or microcapsule used as carriers |
| 04/19/2011 | US7927806 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues |
| 04/19/2011 | US7927803 Human MutY |
| 04/19/2011 | US7927786 Parkin interacting polypeptides and methods of use |
| 04/19/2011 | US7927629 Method and compositions for polymer nanocarriers containing therapeutic molecules |
| 04/19/2011 | US7927626 Biocompatible liquid, biocompatible gas, and solid particles of a biocompatible polymer are mixed together to form a homogenous composition including a discontinuous gas phase with solid particles homogenously dispersed throughout a continuous liquid phase |
| 04/19/2011 | US7927624 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 04/19/2011 | US7927622 Methods of transnasal transport/immunization with highly adaptable carriers |
| 04/19/2011 | US7927621 Thioester-ester-amide copolymers |
| 04/19/2011 | US7927611 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 04/19/2011 | US7927610 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 04/19/2011 | US7927609 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/19/2011 | US7927603 Recombinant fusion-enzyme with repair activity on DNA lesions produced by UV radiation; its usage, preparation and purification method; a method to stabilize enzymes and treatment methods |
| 04/19/2011 | US7927602 Chimeric proteins comprising death domains fused to biotin-streptavidin binding pairs, administered for prophylaxis of asthma, allergies, poisoning, autoimmune or graft versus host disease |